News Headlines Article

False Positives and Real Dollars: Why $88 won’t effectively screen for lung cancer
The Health Care Blog

Let me be clear. I think lung cancer screening is a good thing. The National Lung Cancer Screening Trial (NLST) had air-tight design and was impeccably performed. Those who have paid attention know that the NLST demonstrated a 20% relative reduction in mortality from low-dose CT screening (as opposed to chest x-ray). Plus, the all-cause rate of death in the low-dose CT group was 6.7% lower than the radiography cohort. But the details reveal concerns – those with financial and geographic-specific implications that have, until now, mostly escaped public debate.